Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad35.CS.01 and RTS,S/AS01 Heterologous Prime-Boost in Malaria-Naïve Adults
NCT01366534Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2011
- Primary completion
- Feb 2012
- Modality
- Prophylactic Vaccines, Gene Editing, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of Ad35.CS.01 in malaria, sponsored by GSK. Started Aug 2011; status: completed.
02
Drugs
Ad35.CS.01
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01366534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01366534.